Genexine rights offering by third-party allotment, Oct 16, 2026

Genexine · KOSDAQ · 095700 · Oct 16, 2026 · Rights offerings

Genexine filed a rights offering on Oct 16, 2026. The allocation method is third-party allotment.

Key facts

Allocation methodThird-party allotment

Comparison

Revenue 2025₩4.6bn
Revenue 2024₩2.9bn
Revenue 2023₩4.4bn

Key metrics

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 monthsNot available
Potential new shares, last 12 monthsNot available
Potential new shares, % of sharesNot available
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)